Sexual Differences in response to Mid- or Low-Premixed Insulin Analogue in Patients with Type 2 Diabetes

Table 2

Glycemic variations in patients receiving low- and mid-mixed insulin analogues.

Items	All subjects
	Asp30	Lis50	value
	27 (11, 44)	21(7.75, 37)	0.06
	0 (0, 2)	0 (0, 0)	0.03
Duration 3.9-10			0.01
	0.5 (0.1, 1)	0.4 (0.1, 0.8)	0.08
	0 (0, 0)	0 (0, 0)	0.34
AUC 3.9-10			0.13
24 hr MG			0.08
MAGE			0.56
CV%			0.96
SDMG			0.37

, asp30 vs. lis50. : time spent in glucose levels above 10.0 mmol/L (%); : time spent in glucose levels less than 3.9 mmol/L (%); : the incremental area under curve of (); : the incremental area over curve of plasma (); AUC 3.9-10: the incremental area under the curve of glucose levels between 3.9 and 10 mmol/L; 24 hr MG: 24 hr mean glucose (mmol/L); MAGE: mean amplitude of glycemic excursions (mmol/L); CV%: the coefficient of variation; SDMG: standard deviation (mmol/L).